Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation-Reference-Cited by-同舟云学术

Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation

Published:2021-02-26 Issue:5 Volume:23 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Huang He-Ming¹,Zhou Xiao-Ru²,Liu Yan-Jun¹,Fan Shi-Jie¹,Liao Li-Ping²,Huang Jing²,Shi Cui-Cui¹,Yu Liang²,Pen Jin-Jin¹,Luo Cheng²,Zhang Yuan-Yuan²,Li Guang-Ming¹

Affiliation:

1. Department of Gastroenterology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P.R. China

2. Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Old age as a risk factor for liver diseases: Modern therapeutic approaches;Experimental Gerontology;2023-12

2. Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases;Advanced Drug Delivery Reviews;2023-12

3. Single-cell and spatial heterogeneity landscapes of mature epicardial cells;Journal of Pharmaceutical Analysis;2023-08

4. Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update;Phytomedicine;2023-05

5. Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma;BMC Gastroenterology;2023-01-21